Exjade 250 mg/1
deferasirox · TABLET, FOR SUSPENSION · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
Exjade is a tablet, for suspension containing deferasirox at 250 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- Exjade
- Generic Name
- deferasirox
- NDC Code (Product)
0078-0469- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 250 mg/1
- Dosage Form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- NDA021882
- Drug Class
- Iron Chelator [EPC]
- Marketing Start
- 11/30/2005
Recall History
No Recall HistoryFrequently Asked Questions
What is Exjade used for?
Exjade contains deferasirox. It is a tablet, for suspension taken oral. Consult your doctor for specific uses.
Is Exjade a controlled substance?
Exjade is not classified as a controlled substance by the DEA.
What is the generic name for Exjade?
The generic name for Exjade is deferasirox. There are 11 other brand versions of deferasirox.
What is the NDC code for Exjade 250 mg/1?
The NDC (National Drug Code) for Exjade 250 mg/1 is 0078-0469, listed by Novartis Pharmaceuticals Corporation.